Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Cardiología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome
INTERVENTIONAL
Inicio: 21 de mar de 2018
ID: NCT03473223
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) Who Have Established Atherosclerotic Cardiovascular Disease or Are at Risk for a First Cardiovascular Event - ACCLAIM-Lp(a)
INTERVENTIONAL
Inicio: 5 de mar de 2024
ID: NCT06292013
Completado
Fase 3
ClinicalTrials.gov
A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects With Unstable Angina/Non-ST-Elevation Myocardial Infarction Who Are Medically Managed
INTERVENTIONAL
Inicio: 1 de jun de 2008
ID: NCT00699998
Completado
Fase 2
ClinicalTrials.gov
Multicenter, Single-blind, Randomized, Intraindividual Study of the Safety and Efficacy of Magnevist Gadopentetate Dimeglumine (Magnevist® Injection) at 0.1 and 0.2 mmol/kg for the Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction
INTERVENTIONAL
Inicio: 1 de mar de 2006
ID: NCT00310544
Desconocido
ClinicalTrials.gov
National Registry of Cardiovascular Surgery in Argentine
OBSERVATIONAL
Inicio: 8 de jul de 2021
ID: NCT05199116
Completado
Fase 4
ClinicalTrials.gov
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
INTERVENTIONAL
Inicio: 4 de jun de 2015
ID: NCT02415400
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo Controlled, Multicenter, Phase 3 Study of Rosuvastatin (CRESTOR®) 20 mg in the Prevention of Cardiovascular Events Among Subjects With Low Levels of Low Density Lipoprotein(LDL) Cholesterol & Elevated Levels of C-Reactive Protein
INTERVENTIONAL
Inicio: 1 de feb de 2003
ID: NCT00239681
Completado
Fase 2
ClinicalTrials.gov
A Randomised, Double-blind, Placebo Controlled, Parallel Group, Dose Ranging Study Evaluating the Efficacy and Safety of GW642444M Administered Once Daily Compared With Placebo for 28 Days in Adolescent and Adult Subjects With Persistent Asthma
INTERVENTIONAL
Inicio: 1 de dic de 2007
ID: NCT00600171
Completado
ClinicalTrials.gov
Cardiovascular Risk Stratification of Ambulatory Patients in Primary Prevention. RISK Study
OBSERVATIONAL
Inicio: 1 de jul de 2013
ID: NCT01889030
Desconocido
ClinicalTrials.gov
Discontinuation for Oral Anticoagulants During the First Year of Use in Patients With Atrial Fibrillation Covered by a Medical Insurance
OBSERVATIONAL
Inicio: 4 de abr de 2018
ID: NCT04133545
Desconocido
ClinicalTrials.gov
Effectiveness of Financial Incentives and Text Messages to Improve Health Care of Vulnerable Population With Moderate and High Cardiovascular Risk in Argentina: A Randomized Cluster Trial
INTERVENTIONAL
Inicio: 27 de abr de 2017
ID: NCT03300154
Terminado
Fase 3
ClinicalTrials.gov
A Long-Term Extension, Multi-Center Safety Study of AV-101 in Subjects With Pulmonary Arterial Hypertension (PAH) Who Have Completed Study AV-101-002 (IMPAHCT-FUL)
INTERVENTIONAL
Inicio: 2 de nov de 2022
ID: NCT05557942
Terminado
Fase 3
ClinicalTrials.gov
A Randomised, Multicentre, Double-Blind, Placebo-Controlled Study Of Ambrisentan In Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
INTERVENTIONAL
Inicio: 1 de sept de 2013
ID: NCT01884675
Completado
Fase 3
ClinicalTrials.gov
A 12-week, Double-blind, Randomized Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate / Simvastatin 145/20mg and Fenofibrate / Simvastatin 145/40mg Tablets vs. Matching Monotherapies in Dyslipidemic Subjects at High Risk of Cardiovascular Disease.
INTERVENTIONAL
Inicio: 1 de jun de 2012
ID: NCT01674712
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3540378 in Adults With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)
INTERVENTIONAL
Inicio: 3 de feb de 2023
ID: NCT05592275
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Parallel Group, Phase 3, Efficacy and Safety Study of Ticagrelor Compared With Clopidogrel for Prevention of Vascular Events in Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO- a Study of PLATelet Inhibition and Patient Outcomes]
INTERVENTIONAL
Inicio: 1 de oct de 2006
ID: NCT00391872
Completado
Fase 2
ClinicalTrials.gov
Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of Celivarone at 50, 100 or 300 mg OD With Amiodarone as Calibrator for the Prevention of ICD Interventions or Death
INTERVENTIONAL
Inicio: 1 de sept de 2009
ID: NCT00993382
Terminado
Fase 3
ClinicalTrials.gov
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
INTERVENTIONAL
Inicio: 25 de jun de 2020
ID: NCT04365868
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
INTERVENTIONAL
Inicio: 1 de sept de 2009
ID: NCT00968708
Completado
Fase 4
ClinicalTrials.gov
A Long Term, Randomised, Double Blind, Placebo-controlled Study to Determine the Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de jul de 2015
ID: NCT02465515
Anterior
1
...
38
39
40
...
434
Siguiente
Filtros